WHO strongly recommends antiviral

WHO strongly recommends antiviral drug for patients with non-severe covid-19: A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of...

WHO: Solidarity Therapeutics Trial

Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized...